DrugPatentWatch Database Preview
Drugs in Development Information for Gossypol
Summary for Gossypol
| US Patents | 699 |
| International Patents | 4,304 |
| US Patent Applications | 1,252 |
| WIPO Patent Applications | 923 |
| Japanese Patent Applications | 2 |
| Clinical Trial Progress | Phase 2 (2013-09-01) |
| Vendors | 76 |
US Patents for Gossypol
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Gossypol | ➤ Sign Up | Heterocyclic compounds useful in the treatment of disease | Epigen Biosciences, Inc. (San Diego, CA) | ➤ Sign Up |
| Gossypol | ➤ Sign Up | Pyrazol-3-ones that activate pro-apoptotic BAX | Dana-Farber Cancer Institute, Inc. (Boston, MA) | ➤ Sign Up |
| Gossypol | ➤ Sign Up | Small molecules for the modulation of MCL-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders | Dana-Farber Cancer Institute, Inc. (Boston, MA) | ➤ Sign Up |
| Gossypol | ➤ Sign Up | Methods for sensitizing a quiescent cancer stem cell to a BCR-ABL inhibitor | The Regents of the University of California (Oakland, CA) | ➤ Sign Up |
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
International Patents for Gossypol
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Gossypol | Australia | 2014232383 | 2033-03-15 | ➤ Sign Up |
| Gossypol | Brazil | 112015023267 | 2033-03-15 | ➤ Sign Up |
| Gossypol | Canada | 2906931 | 2033-03-15 | ➤ Sign Up |
| Gossypol | China | 105142635 | 2033-03-15 | ➤ Sign Up |
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
